Although the quality of life is significantly improved in many patients, only about 1/3 of them become insulin independent, 1/3 require minimal insulin replacement (<10 u/day), and the rest develop pancreatogenic diabetes after surgery due to low islet cell survival [2]. The gene discussed is INS; the disease is diabetes mellitus.